Medical Management of Brain Metastases (Q37812446)

23 August 2017

title

Medical Management of Brain Metastases (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

3 September 2024

Nicholas Butowski

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21109146

3 September 2024

publication date

1 January 2011

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1042368010000720?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

https://api.elsevier.com/content/article/PII:S1042368010000720?httpAccept=text/plain

3 September 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Neurosurgery clinics of North America

3 September 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

27-36, v-vi

1 reference

The role of chemotherapy in the treatment of patients with brain metastases from solid tumors

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Brain metastases: epidemiology and pathophysiology.

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Brain metastases: a medical neuro-oncology perspective

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Brain metastases: current management and new developments

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Medical management of brain metastases from lung cancer (Review).

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Brain metastases in breast cancer: prognostic factors and management

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Survival and prognostic factors in patients with brain metastases from malignant melanoma

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Modern multidisciplinary management of brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Evidence-linked, clinical practice guidelines-getting serious; getting professional

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Management of single brain metastasis: a practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Whole brain radiotherapy for the treatment of multiple brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Melanoma-induced brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Current therapeutic approaches in patients with brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Bevacizumab safety in patients with central nervous system metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Systemic treatment in breast-cancer patients with brain metastasis

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Multimodality management of non-small cell lung cancer patients with brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Symptomatic management and imaging of brain metastases

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Prophylactic anticonvulsants in patients with brain tumour.

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

3 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEC.2010.08.004

3 September 2024

Identifiers

1 reference

23 August 2017

1 reference